Chemical industry – Page 82
-
-
Business
EU chemical agency gives first hazardous substance authorisation
Rolls Royce given first approval to use substance linked to birth defects under controlled conditions
-
Business
Kemira now water-based after formic acid sale
Business sold to US agrichemical for €140 million
-
Business
AstraZeneca claims quashed in heartburn drug patent case
Nexium rival does not infringe on patent, court rules
-
Business
Chinese police seize £222m of fake drugs
1300 people are arrested in a nationwide crackdown on counterfeit medicines
-
Business
AstraZeneca shells out $4.1bn for diabetes business
Bristol-Myers Squibb exits the diabetes field with plans to become a specialised biopharmaceutical company
-
Opinion
Cut price pills cost more than pennies
We can’t afford to let the demand for cheaper medicines force compromises on quality, says Steven Ford
-
Business
Court overturns approval to grow GM potato in Europe
Europe’s second highest court rules that European commission did not follow its own rules when giving Amflora the green light
-
Business
Honeywell invests $300m in green refrigerant
New manufacturing plant will produce a gas for car air conditioners that has a much lower global warming potential
-
BusinessLanzatech expands waste-to-chemicals range
Partnership with Evonik will see gas-guzzling microbes make polymer precursors
-
Business
Dow shakes out chlorine business
Company will divest low-margin segments to improve efficiency and focus on higher value specialities
-
Business
Merck KGaA snaps up electronic materials specialist
Firm looks to bolster R&D by acquiring AZ Electronic Materials
-
BusinessNike eliminates water at new Taiwanese dyeing plant
ColorDry process uses supercritical CO2 to reduce waste and cut costs
-
BusinessNew wave of hepatitis C drugs hits US shore
J&J’s once-daily drug approved by FDA, but rivals are hot on its heels
-
Business
US turnaround on Avandia restrictions
Researchers accuse regulator of face-saving U-turn over diabetes medication safety
-
Opinion
Unwelcome festive offerings
It’s not easy to learn you’re going to lose your job, especially at this time of year
-
OpinionPut the chemistry back in medicinal chemistry
Pursuing skewed priorities and easy options has impoverished the pharmaceutical industry, says David Lathbury.
-
OpinionRolling boulders uphill
Is Derek Lowe troubled by his failure to develop a compound that has made it to the pharmacy shelf?